HEADER OXIDOREDUCTASE/INHIBITOR 17-FEB-23 8G89 TITLE HSD17B13 IN COMPLEX WITH COFACTOR AND INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYDROXYSTEROID 17-BETA DEHYDROGENASE 13; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HYDROXYSTEROID 17-BETA DEHYDROGENASE 11; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 GENE: HSD17B13; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: INSECT EXPRESSION VECTOR PBLUEBACMSGCA1HIS KEYWDS 17 BETA-HYDROXYSTEROID DEHYDROGENASE 13; LIPID DROPLET ASSOCIATED KEYWDS 2 PROTEIN; INHIBITOR, OXIDOREDUCTASE, OXIDOREDUCTASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 2 06-SEP-23 8G89 1 JRNL REVDAT 1 09-AUG-23 8G89 0 JRNL AUTH S.LIU,R.F.SOMMESE,N.L.NEDOMA,L.M.STEVENS,J.K.DUTRA,L.ZHANG, JRNL AUTH 2 D.J.EDMONDS,Y.WANG,M.GARNSEY,M.F.CLASQUIN JRNL TITL STRUCTURAL BASIS OF LIPID-DROPLET LOCALIZATION OF JRNL TITL 2 17-BETA-HYDROXYSTEROID DEHYDROGENASE 13. JRNL REF NAT COMMUN V. 14 5158 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37620305 JRNL DOI 10.1038/S41467-023-40766-0 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 68.8 REMARK 3 NUMBER OF REFLECTIONS : 32551 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1607 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 6.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2856 REMARK 3 BIN FREE R VALUE : 0.2505 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 22 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4553 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.84700 REMARK 3 B22 (A**2) : 1.68200 REMARK 3 B33 (A**2) : -0.83500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.304 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.214 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.311 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.218 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4800 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6560 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1665 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 804 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4777 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 658 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3691 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.91 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.86 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.46 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 34.8032 30.071 61.1144 REMARK 3 T TENSOR REMARK 3 T11: -0.1305 T22: -0.2299 REMARK 3 T33: -0.1508 T12: 0.0566 REMARK 3 T13: -0.0422 T23: -0.028 REMARK 3 L TENSOR REMARK 3 L11: 1.6591 L22: 1.0477 REMARK 3 L33: 4.3007 L12: 0.0956 REMARK 3 L13: -0.4432 L23: 0.195 REMARK 3 S TENSOR REMARK 3 S11: 0.0116 S12: 0.0143 S13: 0.6883 REMARK 3 S21: 0.0143 S22: 0.0381 S23: 0.1726 REMARK 3 S31: 0.6883 S32: 0.1726 S33: -0.0497 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.7638 29.7794 84.5116 REMARK 3 T TENSOR REMARK 3 T11: -0.0928 T22: -0.1337 REMARK 3 T33: -0.1469 T12: -0.1198 REMARK 3 T13: -0.0093 T23: 0.0191 REMARK 3 L TENSOR REMARK 3 L11: 2.0267 L22: 1.2519 REMARK 3 L33: 3.8931 L12: -0.5389 REMARK 3 L13: -0.1159 L23: -0.0468 REMARK 3 S TENSOR REMARK 3 S11: -0.0153 S12: 0.0984 S13: 0.701 REMARK 3 S21: 0.0984 S22: 0.0237 S23: -0.5407 REMARK 3 S31: 0.701 S32: -0.5407 S33: -0.0085 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8G89 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000272341. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32599 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.230 REMARK 200 RESOLUTION RANGE LOW (A) : 71.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.47 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 8G84 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG3350, 0.2 M AMMONIUM CHLORIDE, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.51500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 93.23000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.51500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 93.23000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ILE A 287 REMARK 465 GLN A 288 REMARK 465 PHE A 289 REMARK 465 GLU A 290 REMARK 465 ALA A 291 REMARK 465 VAL A 292 REMARK 465 ILE A 293 REMARK 465 GLY A 294 REMARK 465 HIS A 295 REMARK 465 LYS A 296 REMARK 465 THR A 297 REMARK 465 ARG A 298 REMARK 465 MET A 299 REMARK 465 LYS A 300 REMARK 465 GLY A 301 REMARK 465 SER A 302 REMARK 465 GLY A 303 REMARK 465 HIS A 304 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 HIS A 309 REMARK 465 HIS A 310 REMARK 465 HIS A 311 REMARK 465 HIS A 312 REMARK 465 HIS A 313 REMARK 465 HIS A 314 REMARK 465 MET B 0 REMARK 465 GLY B 1 REMARK 465 LYS B 296 REMARK 465 THR B 297 REMARK 465 ARG B 298 REMARK 465 MET B 299 REMARK 465 LYS B 300 REMARK 465 GLY B 301 REMARK 465 SER B 302 REMARK 465 GLY B 303 REMARK 465 HIS B 304 REMARK 465 HIS B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 465 HIS B 310 REMARK 465 HIS B 311 REMARK 465 HIS B 312 REMARK 465 HIS B 313 REMARK 465 HIS B 314 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 60 31.10 70.94 REMARK 500 ALA A 127 150.97 176.13 REMARK 500 ILE A 145 -50.65 -143.71 REMARK 500 ALA A 171 -108.64 -100.04 REMARK 500 SER A 172 166.91 169.80 REMARK 500 PRO A 229 -165.67 -105.63 REMARK 500 THR A 231 103.62 -59.87 REMARK 500 GLU A 275 -10.08 -144.48 REMARK 500 LYS B 60 31.84 70.95 REMARK 500 VAL B 111 -51.41 -121.36 REMARK 500 ALA B 127 150.68 176.63 REMARK 500 ILE B 145 -50.74 -144.19 REMARK 500 ALA B 171 -109.15 -100.66 REMARK 500 SER B 172 167.10 169.88 REMARK 500 VAL B 219 -159.12 -82.02 REMARK 500 GLU B 275 -56.84 71.11 REMARK 500 PHE B 289 145.56 179.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8G84 RELATED DB: PDB REMARK 900 APO DOG STRUCTURE DBREF1 8G89 A 2 300 UNP A0A8C0PP93_CANLF DBREF2 8G89 A A0A8C0PP93 2 300 DBREF1 8G89 B 2 300 UNP A0A8C0PP93_CANLF DBREF2 8G89 B A0A8C0PP93 2 300 SEQADV 8G89 MET A 0 UNP A0A8C0PP9 INITIATING METHIONINE SEQADV 8G89 GLY A 1 UNP A0A8C0PP9 CLONING ARTIFACT SEQADV 8G89 GLY A 301 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 SER A 302 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 GLY A 303 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 304 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 305 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 306 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 307 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 308 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 309 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 310 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 311 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 312 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 313 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS A 314 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 MET B 0 UNP A0A8C0PP9 INITIATING METHIONINE SEQADV 8G89 GLY B 1 UNP A0A8C0PP9 CLONING ARTIFACT SEQADV 8G89 GLY B 301 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 SER B 302 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 GLY B 303 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 304 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 305 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 306 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 307 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 308 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 309 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 310 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 311 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 312 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 313 UNP A0A8C0PP9 EXPRESSION TAG SEQADV 8G89 HIS B 314 UNP A0A8C0PP9 EXPRESSION TAG SEQRES 1 A 315 MET GLY ASN ILE ILE LEU ASP LEU LEU LEU LEU LEU LEU SEQRES 2 A 315 THR ILE ILE TYR SER TYR LEU GLU ALA LEU VAL LYS VAL SEQRES 3 A 315 PHE PHE PRO ARG LYS ARG LYS SER VAL ALA GLY GLU ILE SEQRES 4 A 315 VAL LEU ILE THR GLY ALA GLY HIS GLY ILE GLY ARG TRP SEQRES 5 A 315 THR ALA TYR GLU PHE ALA LYS GLN LYS SER ARG LEU VAL SEQRES 6 A 315 LEU TRP ASP ILE ASN LYS HIS GLY VAL GLU GLU THR ALA SEQRES 7 A 315 ALA GLU CYS ARG LYS LEU GLY ALA THR VAL HIS THR PHE SEQRES 8 A 315 VAL VAL ASP CYS GLY ASN ARG GLU ASP ILE TYR ASN SER SEQRES 9 A 315 VAL LYS GLN VAL LYS LYS GLU VAL GLY ASP VAL THR ILE SEQRES 10 A 315 LEU VAL ASN ASN ALA GLY THR VAL TYR PRO ALA ASP LEU SEQRES 11 A 315 LEU SER THR LYS ASP GLU GLU ILE THR LYS THR PHE GLU SEQRES 12 A 315 ILE ASN ILE LEU GLY HIS PHE TRP ILE THR LYS ALA LEU SEQRES 13 A 315 LEU PRO SER MET ILE LYS ARG ASN HIS GLY HIS ILE VAL SEQRES 14 A 315 THR VAL ALA SER VAL CYS GLY HIS GLY VAL ILE PRO TYR SEQRES 15 A 315 LEU ILE PRO TYR CYS SER SER LYS PHE ALA ALA VAL GLY SEQRES 16 A 315 PHE HIS ARG ALA LEU THR LEU GLU LEU GLN THR LEU GLY SEQRES 17 A 315 ILE THR GLY ILE LYS THR SER CYS LEU CYS PRO VAL PHE SEQRES 18 A 315 VAL ASN THR GLY PHE THR LYS ASN PRO SER THR ARG LEU SEQRES 19 A 315 TRP PRO ILE LEU GLU THR ASP THR VAL ALA ARG SER LEU SEQRES 20 A 315 ILE ASP GLY ILE LEU THR ASN LYS LYS MET ILE PHE VAL SEQRES 21 A 315 PRO SER TYR TYR ASN ILE TYR LEU ILE LEU ASP LYS PHE SEQRES 22 A 315 LEU PRO GLU ARG ALA LEU ALA ALA ILE ASN HIS LEU GLN SEQRES 23 A 315 ASN ILE GLN PHE GLU ALA VAL ILE GLY HIS LYS THR ARG SEQRES 24 A 315 MET LYS GLY SER GLY HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 25 A 315 HIS HIS HIS SEQRES 1 B 315 MET GLY ASN ILE ILE LEU ASP LEU LEU LEU LEU LEU LEU SEQRES 2 B 315 THR ILE ILE TYR SER TYR LEU GLU ALA LEU VAL LYS VAL SEQRES 3 B 315 PHE PHE PRO ARG LYS ARG LYS SER VAL ALA GLY GLU ILE SEQRES 4 B 315 VAL LEU ILE THR GLY ALA GLY HIS GLY ILE GLY ARG TRP SEQRES 5 B 315 THR ALA TYR GLU PHE ALA LYS GLN LYS SER ARG LEU VAL SEQRES 6 B 315 LEU TRP ASP ILE ASN LYS HIS GLY VAL GLU GLU THR ALA SEQRES 7 B 315 ALA GLU CYS ARG LYS LEU GLY ALA THR VAL HIS THR PHE SEQRES 8 B 315 VAL VAL ASP CYS GLY ASN ARG GLU ASP ILE TYR ASN SER SEQRES 9 B 315 VAL LYS GLN VAL LYS LYS GLU VAL GLY ASP VAL THR ILE SEQRES 10 B 315 LEU VAL ASN ASN ALA GLY THR VAL TYR PRO ALA ASP LEU SEQRES 11 B 315 LEU SER THR LYS ASP GLU GLU ILE THR LYS THR PHE GLU SEQRES 12 B 315 ILE ASN ILE LEU GLY HIS PHE TRP ILE THR LYS ALA LEU SEQRES 13 B 315 LEU PRO SER MET ILE LYS ARG ASN HIS GLY HIS ILE VAL SEQRES 14 B 315 THR VAL ALA SER VAL CYS GLY HIS GLY VAL ILE PRO TYR SEQRES 15 B 315 LEU ILE PRO TYR CYS SER SER LYS PHE ALA ALA VAL GLY SEQRES 16 B 315 PHE HIS ARG ALA LEU THR LEU GLU LEU GLN THR LEU GLY SEQRES 17 B 315 ILE THR GLY ILE LYS THR SER CYS LEU CYS PRO VAL PHE SEQRES 18 B 315 VAL ASN THR GLY PHE THR LYS ASN PRO SER THR ARG LEU SEQRES 19 B 315 TRP PRO ILE LEU GLU THR ASP THR VAL ALA ARG SER LEU SEQRES 20 B 315 ILE ASP GLY ILE LEU THR ASN LYS LYS MET ILE PHE VAL SEQRES 21 B 315 PRO SER TYR TYR ASN ILE TYR LEU ILE LEU ASP LYS PHE SEQRES 22 B 315 LEU PRO GLU ARG ALA LEU ALA ALA ILE ASN HIS LEU GLN SEQRES 23 B 315 ASN ILE GLN PHE GLU ALA VAL ILE GLY HIS LYS THR ARG SEQRES 24 B 315 MET LYS GLY SER GLY HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 25 B 315 HIS HIS HIS HET NAD A 401 44 HET YXW A 402 51 HET NAD B 401 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM YXW 3-FLUORO-N-({(1R,4R)-4-[(2-FLUOROPHENOXY)METHYL]-1- HETNAM 2 YXW HYDROXYCYCLOHEXYL}METHYL)-4-HYDROXYBENZAMIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 YXW C21 H23 F2 N O4 FORMUL 6 HOH *81(H2 O) HELIX 1 AA1 ASN A 2 PHE A 27 1 26 HELIX 2 AA2 HIS A 46 GLN A 59 1 14 HELIX 3 AA3 ASN A 69 LEU A 83 1 15 HELIX 4 AA4 ASN A 96 VAL A 111 1 16 HELIX 5 AA5 ASP A 128 THR A 132 5 5 HELIX 6 AA6 LYS A 133 ILE A 145 1 13 HELIX 7 AA7 ILE A 145 ASN A 163 1 19 HELIX 8 AA8 SER A 172 HIS A 176 5 5 HELIX 9 AA9 LEU A 182 LEU A 206 1 25 HELIX 10 AB1 GLU A 238 THR A 252 1 15 HELIX 11 AB2 TYR A 262 LYS A 271 1 10 HELIX 12 AB3 GLU A 275 LEU A 284 1 10 HELIX 13 AB4 ILE B 3 PHE B 27 1 25 HELIX 14 AB5 HIS B 46 GLN B 59 1 14 HELIX 15 AB6 ASN B 69 LEU B 83 1 15 HELIX 16 AB7 ASN B 96 VAL B 111 1 16 HELIX 17 AB8 ASP B 128 THR B 132 5 5 HELIX 18 AB9 LYS B 133 ILE B 145 1 13 HELIX 19 AC1 ILE B 145 ASN B 163 1 19 HELIX 20 AC2 SER B 172 HIS B 176 5 5 HELIX 21 AC3 LEU B 182 LEU B 206 1 25 HELIX 22 AC4 GLU B 238 THR B 252 1 15 HELIX 23 AC5 TYR B 262 LYS B 271 1 10 HELIX 24 AC6 GLU B 275 ASN B 286 1 12 SHEET 1 AA1 7 VAL A 87 VAL A 91 0 SHEET 2 AA1 7 ARG A 62 ASP A 67 1 N LEU A 65 O HIS A 88 SHEET 3 AA1 7 ILE A 38 THR A 42 1 N VAL A 39 O ARG A 62 SHEET 4 AA1 7 ILE A 116 ASN A 119 1 O VAL A 118 N LEU A 40 SHEET 5 AA1 7 GLY A 165 VAL A 170 1 O VAL A 168 N LEU A 117 SHEET 6 AA1 7 ILE A 211 PRO A 218 1 O SER A 214 N THR A 169 SHEET 7 AA1 7 MET A 256 VAL A 259 1 O ILE A 257 N CYS A 217 SHEET 1 AA2 7 VAL B 87 VAL B 91 0 SHEET 2 AA2 7 ARG B 62 ASP B 67 1 N LEU B 65 O HIS B 88 SHEET 3 AA2 7 ILE B 38 THR B 42 1 N VAL B 39 O VAL B 64 SHEET 4 AA2 7 ILE B 116 ASN B 119 1 O VAL B 118 N LEU B 40 SHEET 5 AA2 7 GLY B 165 VAL B 170 1 O VAL B 168 N LEU B 117 SHEET 6 AA2 7 ILE B 211 PRO B 218 1 O SER B 214 N THR B 169 SHEET 7 AA2 7 MET B 256 VAL B 259 1 O ILE B 257 N CYS B 217 CISPEP 1 VAL A 259 PRO A 260 0 -0.59 CISPEP 2 PRO A 274 GLU A 275 0 -1.67 CISPEP 3 VAL B 259 PRO B 260 0 -0.15 CRYST1 77.030 186.460 65.470 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012982 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005363 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015274 0.00000